Cleared Traditional

K220417 - Spectrum IQ Infusion System with Dose I...

K220417 is the FDA 510(k) clearance for Spectrum IQ Infusion System with Dose I... by Baxter Healthcare Corporation. It is a Class 2 General Hospital device (product code FRN) cleared through the Traditional 510(k) pathway after a 74-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2022
Decision
74d
Days
Class 2
Risk

K220417 is an FDA 510(k) clearance for the Spectrum IQ Infusion System with Dose IQ Safety Software. Classified as Pump, Infusion (product code FRN), Class II - Special Controls.

Submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on April 29, 2022 after a review of 74 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5725 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Baxter Healthcare Corporation devices

Submission Details

510(k) Number K220417 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 14, 2022
Decision Date April 29, 2022
Days to Decision 74 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 129d · This submission: 74d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FRN Pump, Infusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FRN Pump, Infusion

All 433
Devices cleared under the same product code (FRN) and FDA review panel - the closest regulatory comparables to K220417.
Spectrum IQ Infusion System with Dose IQ Safety Software
K222048 · Baxter Healthcare Corporation · Sep 2022
Novum IQ Syringe Pump
K211125 · Baxter Healthcare Corporation · Aug 2022
FreedomEdge Syringe Infusion System
K214045 · Repro-Medical System, Inc., Dba Koru Medical Systems · Apr 2022
Agilia VP Infusion System, Agilia VP MC WIFI Infusion Pump, Volumat Lines Administration Sets, Agilia Link, Agilia Duo
K210073 · Fresenius Kabi AG · Mar 2022
Agilia SP Infusion System, Agilia SP MC WIFI Infusion Pump, Agilia Link, Agilia Duo, Agilia USB Cable
K210074 · Fresenius Kabi AG · Mar 2022
FREEDOM Integrated Syringe Infusion System
K200176 · Repro-Med Systems, Inc. Dba Koru Medical Systems · Dec 2021